EARNINGS: Merck beats on Keytruda, Januvia/Janumet revenue, misses on Remicade, Zepatier

Yahoo Finance Video

Yahoo Finance's Jared Blikre and Alexis Christoforous break down the latest market action after the drugmaker reported Q1 2018 earnings.

Scroll to continue with content
Ad

What to Read Next